Neuropathic pain and symptoms of potential small-fiber neuropathy in fibromyalgic patients: A national on-line survey - 05/06/21
, Tommaso Geri a, 1, Simone De Luca a, Filippo Maselli a, Giacomo Rossettini a, Alberto Sulli b, Angelo Schenone a, c, Marco Testa aBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 8 |
| Iconographies | 3 |
| Vidéos | 0 |
| Autres | 0 |
Highlights |
• | Neuropathic symptoms are highly prevalent in our cohort of fibromyalgic patients. |
• | Diagnostic test to confirm small-fibers involvement were sparsely reported. |
• | Detecting neuropathic symptoms may assist clinicians in therapeutic management. |
Abstract |
Objective |
Recent studies have highlighted that about 50% of fibromyalgic patients has a neuropathy of small- and/or large-fibers which could partially explain the puzzling symptoms of fibromyalgia (FM). Our aim was to investigate the estimated prevalence of self-reported neuropathic pain and small-fiber neuropathic symptoms (SFNS) indicative for the presence of small-fiber pathology in FM patients.
Methods |
A nationwide sample of patients was recruited to participate in an on-line survey. Two groups of patients were considered in post-hoc analysis: those positive (FM+) to the Fibromyalgia Research Criteria (FRC) and those complaining typical symptoms of fibromyalgia without fulfilling the FRC (FM−).
Results |
We collected data from 854 patients (749 FM+ and 105 FM−). Patients that scored=50/100 at the Neuropathic Pain Symptoms Inventory (NPSI), indicating severe neuropathic pain, were 57.3% (62.4% in FM+ and 21.0% in FM−). Around 46% of patients presented three or more SFNS that could be suggestive of small fiber pathology, the most frequent being dry eyes/mouth, allodynia, and dyshidrosis. The NPSI score showed significant moderate/strong associations with disability (Spearman's rho=0.61), pain (rho=0.66), stiffness level (rho=0.46), number of painful sites (rho=0.40), and SFNS (rho=0.44). Despite the high prevalence of neuropathic pain and other symptoms attributable to potential small and/or large fibers pathology, neurophysiologic investigations were performed in 43.6% of cases and skin punch biopsy only in 1.9% of patients enrolled, as well as the assumption of anti-neuropathic pain drugs (13.2%).
Conclusions |
Our findings underscore the high estimated prevalence of neuropathic pain and SFNS in FM patients.
Le texte complet de cet article est disponible en PDF.Keywords : Neuropathic pain, Fibromyalgia, Small fiber neuropathy, Survey
Plan
Vol 88 - N° 4
Article 105153- juillet 2021 Retour au numéro
Article précédent
- The DIGICOD cohort: A hospital-based observational prospective cohort of patients with hand osteoarthritis – methodology and baseline characteristics of the population
- Jérémie Sellam, Emmanuel Maheu, Michel D. Crema, Amel Touati, Alice Courties, Sophie Tuffet, Alexandra Rousseau, Xavier Chevalier, Bernard Combe, Maxime Dougados, Bruno Fautrel, Margreet Kloppenburg, Jean-Denis Laredo, Damien Loeuille, Anne Miquel, François Rannou, Pascal Richette, Tabassome Simon, Francis Berenbaum
- Mitral valve granulomatosis: A paradoxical reaction complicating etanercept treatment in rheumatoid arthritis. A case report
- Caroline Ngoufack, Luca Semerano, Isabelle Podglajen, Patrick Bruneval, Christophe Meune, Dominique Valeyre, Robin Dhote, Marie-Christophe Boissier, Nathalie Saidenberg-Kermanac’h
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?